This is the website of Smart Pharma and its proprietary computational drug discovery platform Smart-ACTTM. If you are interested in exploring the SMPT tokens, a security SMPT token is created to sponsor drug development projects under the Smart-ACTTM platform, please visit its website at https://smtph.io.
About Smart Pharma Group
Smart Pharma Group includes Smart Pharmaceutical Limited Partnership, SMTPH Limited and its subsidiaries. The Smart Pharma Group is wholly owned by Aptorum Group Limited. Smart Pharma Group focuses on systematically repurposing existing approved drugs for the treatment of a large array of orphan diseases. Smart Pharma Group conducts both computational based screening and preclinical validations in advancing the development of its repurposed candidates.